1. Pharmacokinetic Profile of Orally Administered Scyllo‐Inositol (Elnd005) in Plasma, Cerebrospinal Fluid and Brain, and Corresponding Effect on Amyloid‐Beta in Healthy Subjects. Issue 2 (16th March 2013) Authors: Liang, Earvin; Garzone, Pamela; Cedarbaum, Jesse M.; Koller, Martin; Tran, Thao; Xu, Victor; Ross, Brian; Jhee, Stanford S.; Ereshefsky, Larry; Pastrak, Aleksandra; Abushakra, Susan Journal: Clinical pharmacology in drug development Issue: Volume 2:Issue 2(2013:Apr.) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program. (June 2014) Authors: Bigal, Marcelo E; Escandon, Rafael; Bronson, Michele; Walter, Sarah; Sudworth, Maria; Huggins, John P; Garzone, Pamela Journal: Cephalalgia Issue: Volume 34:Number 7(2014) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗